The biggest insider story this week centres on CVS Health. Board member Lawrence Robbins filed a combined $262M in sales this week, offloading nearly 2.8 million shares between May 19–20 at around $94 each. That is one of the largest single-director disposals seen in US markets recently.
Over at MPWR, founder and CEO Michael Hsing filed $55M in sales on May 20. Hsing sold across multiple tranches at prices between $1,463 and $1,508 per share. The filings came just days after the trades were executed on May 18.
CVX Director John Hess — son of the Hess Corporation founder — filed $71M in Chevron sales on May 22. The trades occurred on May 20, at prices ranging from $192 to $197 per share.
On the buying side, Capital Group disclosed a $285M stake increase in ONC, oncology firm BeOne Medicines, filed May 22. That signals strong institutional conviction in the biotech space.
Meanwhile, BSX saw three separate insiders file purchases this week. Boston Scientific's cluster of buys — with zero selling — points to quiet confidence from within the medical device giant.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
